Longboard Pharmaceuticals
Rosa Chan, PhD, is currently a Director of Clinical Pharmacology at Longboard Pharmaceuticals (now a subsidiary of Lundbeck). She earned her Ph.D. from the University of California San Francisco under the guidance of Dr. Leslie Benet. Rosa has more than 9 years of industrial experience in the development of large and small molecule drugs with a focus on clinical pharmacology and pharmacometrics. She has been a member of ASCPT since 2018.